معرفی
Uwe Himmelreich is a Full Professor at the Faculty of Medicine, KU Leuven, leading the Biomedical MRI unit. He is actively involved in the Medical Imaging Division, KU Leuven Brain Institute, KU Leuven Institute for Integration of Micro- and Nano-scale Technologies, and KU Leuven Cancer Institute.
- Role: Full Professor and Head of Biomedical MRI
- Affiliations: Faculty of Medicine, Medical Imaging Division, LBI, LIMNI, LKI
His research spans neuroscience, cardiovascular imaging, and nano/micro-scale technologies. Key projects include:
- MindMAP: Radiotherapy-induced neurotoxicity in juvenile brains
- Preclinical cancer models for oral tumors
- Quantitative T2 mapping of lung disease in murine models
- Neuroinflammation and cognitive decline in cryptococcosis
- Resistance training effects on cortical thickness in aging cohorts
His work integrates MRI, multi-photon microscopy, and novel contrast agents for longitudinal in vivo studies. Methodologies include vascular density mapping, proton therapy verification, and preclinical radiotherapy evaluation.
Notable contributions include:
- 2025: JAK/STAT inhibition in malaria-induced inflammation
- 2025: Manganese-enhanced MRI for cardiac injury
- 2025: Quantitative lung imaging at 9.4T
- 2024: IVIM as vascular density marker in rat brain
- 2024: Phase-change ultrasound agents for proton therapy
۰مقاله منتشرشده